Bone marrow transplantation for Epsteinwas negative for EBV antibodies. The conditioning regimen follows: intrathecal MTX/Ara-C/Pred (day −11), TBI
associated with hemophagocytosis
4 mg/kg/day × 2 days (day −6, −5) and L-PAM 70 mg/m 2 /day × 3 days (day −4, −3, −2); 4.2 × 10 8 /kg donor bone marrow cells were infused. As GVHD prophylaxis, Teshima and colleagues 1 reported the case of a 12-yearold girl who was successfully treated with bone marrow two doses of MTX (day +1, +3) and cyclosporine were given. The post-BMT course was uneventful with no acute transplantation (BMT) for Epstein-Barr virus (EBV)-associated natural killer (NK) cell-large granular lymphocyte GVHD and neutrophils rose to 500 × 10 6 /l at day +13; the last platelet transfusion was given at day +11. Bone marrow leukemia. Besides NK cell type malignancy, EBV-related clonal peripheral T cell lymphoproliferative disease has cells at day +14 demonstrated an engraftment (by FISH, 46XY = 99.7%) without bizarre-looking LGLs. EBV genalso been reported to be fatal. [2] [3] [4] We report here a 5-yearold girl who developed persistent fever, pancytopenia, ome was negative in two successive bone marrow aspirations and no post-BMT lymphoproliferative disease has hepatosplenomegaly, liver dysfunction, pericardial effusion and coagulopathy in November 1995.
occurred. As of December 1996, 7 months after the BMT, the patient is doing well without recurrence of the disease. On admission, the patient had WBC 1500 × 10 6 /l Hb 83 g/l and platelet count 28 000 × 10 6 /l. Large atypical In addition to Teshima et al's report, successful allogeneic BMT has previously been documented for cases lymphoid cells were noted to be 11.0% in peripheral blood and 37.0% in bone marrow which displayed mature T cell with EBV-related X-linked lymphoproliferative disease 6 and hemophagocytic lymphohistiocytosis. 7 As to the markers. Hemophagocytes were noted in bone marrow smears. Blood chemistry revealed AST 841 (normal Ͻ40) conditioning regimens, TBI/VP16/CY, 1 CY/TBI, BU/CY/VP16, BU/AraC/CY, CY/L-PAM/ATG, 6 and IU/l. ALT 211 (normal Ͻ35) IU/l, LDH 7158 (normal Ͻ430) IU/l, total bilirubin 26.4 (normal Ͻ1.2) mg/l, beta-VP16/BU/CY ± ATG (or OKT3) 7 were used in the published cases; however, we employed a TBI (12 Gy)/BU 2-microglobulin (MG) 58.6 (normal Ͻ2.4) mg/l and ferritin 49 800 (normal Ͻ78) g/l. Urine beta-2-MG was also sig-(8 mg/kg)/L-PAM (210 mg/m 2 ) combination for this case, which has currently been demonstrated to be an effective nificantly elevated with 437 904 (normal Ͻ200) g/g creatinine. Serum soluble interleukin-2 receptor, interferonand safe regimen in allogeneic BMT for pediatric patients with malignancies. gamma and interleukin-6 were elevated with 14 700 (normal Ͻ1090) U/ml, 466 (normal Ͻ1.0) U/ml and 68. 2 We think that this case is the first documentation of a successful transplant for a very aggressive EBV-related T (normal Ͻ4.0) pg/ml, respectively. EBV serology showed viral capsid antigen (VCA)-IgG ×640, -IgM Ͻ×10, early cell-type clonal disease associated with hemophagocytic syndrome, which is reported to have a dismal outcome.
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antigen for DR components (EADR)-IgG ×40 and EBV nuclear antigen (EBNA) Ͻ×10; EBV genome was positive We propose that allogeneic BMT should be attempted for aggressive cases of EBV-related clonal diseases as well as by polymerase chain reaction in the peripheral blood. Monoclonality for mononuclear cells in the bone marrow other poor prognostic EBV-related disorders such as chronic active EBV infection. 8 was confirmed by a single band by Southern analysis using a probe for EBV terminal repeat and also by demonstrating T cell receptor (TCR) beta-rearrangement bands. No abnor-S Imashuku cancer drugs. In addition, every episode of spiky fever was associated with a sharp rise in urinary beta-2-MG. After the recurrence, bizarre-looking large granular lymphocytes (LGLs) appeared both in the peripheral blood and bone References marrow. 5 Because of refractoriness to any chemotherapy and the development of pulmonary edema and disseminated
